Symbol="RCKT"
AssetType="Common Stock"
Name="Rocket Pharmaceuticals Inc"
Description="Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey."
CIK="1281895"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1604398000"
EBITDA="-239172992"
PERatio="None"
PEGRatio="None"
BookValue="5.71"
DividendPerShare="0"
DividendYield="0"
EPS="-3.44"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.312"
ReturnOnEquityTTM="-0.541"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.44"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="51.91"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.072"
EVToRevenue="-"
EVToEBITDA="-6.39"
Beta="1.169"
num_52WeekHigh="24.53"
num_52WeekLow="11.78"
num_50DayMovingAverage="21.01"
num_200DayMovingAverage="19.23"
SharesOutstanding="80461000"
DividendDate="2018-01-05"
ExDividendDate="None"
symbol="RCKT"
open="19.95"
high="20.10"
low="19.66"
price="19.92"
volume="401699.00"
latest_trading_day="2023-07-13"
previous_close="19.94"
change="-0.02"
change_percent="-0.1003%"
aroon_positive_momentum_days="50"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="796537"
Change_recent_avg="0.01"
Delta_recent_avg="0.97"
Variance_recent_avg="0.48"
Change_ratio_recent_avg="-0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="970"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0132.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
